6MD vs KURN: Side-by-Side Comparison
Compare MEDACTA GROUP S.A. SF-,10 (6MD) and Kuros Biosciences AG (KURN) side by side: market cap EUR 2.81B vs CHF 755.26M, P/E 29.5 vs 319.2. Financials, growth and model signals on Bullrun.
| Metric | 6MD | KURN |
|---|---|---|
| Company | MEDACTA GROUP S.A. SF-,10 | Kuros Biosciences AG |
| Country / Exchange | Switzerland · F | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Market cap | EUR 2.81B | CHF 755.26M |
| P/E ratio | 29.5 | 319.2 |
| Dividend yield | 0.81% | — |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 683.83M | CHF 146.06M |
| Revenue growth YoY | +15.8% | +71.5% |
| Net income | EUR 95.46M | CHF 2.55M |
| Gross margin | 67.1% | 88.6% |
| Diluted EPS | — | — |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.